You just read:

INTERCURE: CANNDOC Initiates Phase 3 Clinical Trial Evaluating Pharma Grade Medicinal Cannabis (CANNDOC T1/C20) For Children With Autism Spectrum Disorder

News provided by

InterCure Ltd.

21 Nov, 2019, 21:22 IST